Regulation & Compliance

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

Amidst rising costs and market volatility, Centene appoints two new Group Presidents. Is this strategic overhaul the key to future growth and profitability?

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

The promise of cash pay in construction hides a dark reality of worker exploitation and a $23 billion underground economy. A new campaign aims to change that.

Emerging player LunR Royalties finalizes a transformational silver stream on the Fruta Del Norte mine, a move poised to reshape its future and reward Lundin Gold's investors.

As PharmaCorp Rx prepares for a key investor conference, its strategy of consolidating independent pharmacies faces a pivotal test of market confidence.

The global broker adds a new layer of security with independent dispute resolution and a €20,000 compensation fund. What does this mean for traders?

As a critical FDA drug safety reporting deadline looms, a new cloud tool helps smaller biotech and pharma firms avoid costly penalties and level the field.

A new tool reveals how a federal drug program may be inflating healthcare costs for businesses, intensifying the debate over transparency and reform.

Healthee's AI platform is now part of the Workday Wellness Program, promising to demystify health plans and cut costs for millions of employees.

Canada's largest primary care congress convenes leaders to debate AI, funding, and patient access amid a deepening healthcare crisis. Will it deliver solutions?

USBC divests its sensor business to fully focus on tokenized deposits, a bold pivot into the risky but potentially revolutionary future of digital finance.

The YMCA, FINAO, and Rubix are building a blockchain-powered wellness platform to incentivize health, ensure data privacy, and combat soaring medical costs.

Postquant Labs' new testnet merges D-Wave's quantum power with blockchain, aiming to build a quantum-proof digital asset ecosystem for a global community.

As AI reshapes creative fields, Minted's Independent Artist Day celebrates a powerful counter-narrative: technology can empower, not erase, human creativity.

Trailblazing public defender Cuauhtémoc Ortega joins an elite boutique, a move signaling a major shift in LA's high-stakes litigation landscape.

As teen HPV vaccination rates stagnate, a new national campaign urges families to fight online falsehoods by turning to their most trusted source: their doctor.

Demand The Limits Injury Attorneys' client-first model fuels explosive growth, earning a top spot on Inc.'s prestigious Southeast list despite new hurdles.

With a $60M war chest, Gyde acquires a top Medicare agency to deploy its AI platform, aiming to blend high-tech efficiency with a human touch.

After 40 years as a silent partner to global brands, Intercon Chemical is launching its own high-stakes medical cleaning lines to meet new safety standards.